- Palbociclib Induces Senescence in Melanoma and Breast Cancer Cells and Leads to Additive Growth Arrest in Combination With Irradiation
Tina Jost et al, 2021, Frontiers in Oncology CrossRef - Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients
Tina Jost et al, 2022, Strahlentherapie und Onkologie CrossRef - Current trends and future prospects of drug repositioning in gastrointestinal oncology
Nayeralsadat Fatemi et al, 2024, Frontiers in Pharmacology CrossRef - The Anti-Angiogenic Effects of Anti-Human Immunodeficiency Virus Drugs
Giovanni Barillari, 2020, Frontiers in Oncology CrossRef - The Antiviral Drug Efavirenz in Breast Cancer Stem Cell Therapy
Pey-Tsyr Chiou et al, 2021, Cancers CrossRef - PARP Inhibitors Talazoparib and Niraparib Sensitize Melanoma Cells to Ionizing Radiation
Stephanie Jonuscheit et al, 2021, Genes CrossRef - Efavirenz and Lopinavir/Ritonavir Alter Cell Cycle Regulation in Lung Cancer
Rahaba Marima et al, 2020, Frontiers in Oncology CrossRef - Efavirenz as a potential drug for the treatment of triple-negative breast cancers
P.-T. Chiou et al, 2021, Clinical and Translational Oncology CrossRef - Drug Repositioning: A Monetary Stratagem to Discover a New Application of Drugs
Ankur Rohilla et al, 2024, Current Drug Discovery Technologies CrossRef - Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells
Eva-Maria Faulhaber et al, 2021, Genes CrossRef - Dual mTOR/DNA-PK Inhibitor CC-115 Induces Cell Death in Melanoma Cells and Has Radiosensitizing Potential
Felix Bürkel et al, 2020, International Journal of Molecular Sciences CrossRef - Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?
Christina Pfab et al, 2021, Cancers CrossRef - Efavirenz induces DNA damage response pathway in lung cancer
Rahaba Marima et al, 2020, Oncotarget CrossRef - Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates
Laura De Lellis et al, 2021, Cancers CrossRef